References
- Snyder LA, Rismondo V, Miller NR. The fisher variant of Guillain-Barré syndrome (Fisher syndrome). J Neuro-Ophthalmol 2009;29:312–324. doi: 10.1097/WNO.0b013e3181c2514b.
- Wakerley BR, Uncini A, Yuki N, GBS Classification Group. Guillain-Barré and Miller Fisher syndromes—new diagnostic classification. Nat Rev Neurol 2014;10:537–544. doi: 10.1038/nrneurol.2014.138.
- Spatola M, Du Pasquier R, Schluep M, Regeniter A. Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes. Neurology 2016;86:1780–1784. doi: 10.1212/WNL.0000000000002558.
- Liu JX, Willison HJ, Pedrosa-Domellöf F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci 2009;50:3226–3232. doi: 10.1167/iovs.08-3333.
- Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104–1106. doi: 10.1212/WNL.56.8.1104.
- Koga M, Gilber M, Li J, Koike S, Takahashi M, Furukawa K, Hirata K, Yuki N. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 2005;64:1605–1611. doi: 10.1212/01.WNL.0000160399.08456.7C.
- Yuki N, Hirata K. Fisher’s syndrome and group A streptococcal infection. J Neurol Sci 1998;160:64–66. doi: 10.1016/S0022-510X(98)00220-2.
- Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol 2004;148:200–205. doi: 10.1016/j.jneuroim.2003.11.017.
- Yuki N, Odaka M, Hirata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology 2001;108:196–200. doi: 10.1016/S0161-6420(00)00420-6.
- Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911–1911. doi: 10.1212/WNL.43.10.1911.